GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (FRA:45O) » Definitions » Pre-Tax Income

Orgenesis (FRA:45O) Pre-Tax Income : €-47.22 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Orgenesis's pretax income for the three months ended in Mar. 2024 was €-9.19 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €-47.22 Mil. Orgenesis's pretax margin was -7,069.23%.

During the past 13 years, Orgenesis's highest Pretax Margin was -33.20%. The lowest was -12159.43%. And the median was -180.26%.


Orgenesis Pre-Tax Income Historical Data

The historical data trend for Orgenesis's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Pre-Tax Income Chart

Orgenesis Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.54 -79.52 -15.89 -11.29 -59.10

Orgenesis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.71 -28.71 -3.12 -6.20 -9.19

Competitive Comparison of Orgenesis's Pre-Tax Income

For the Biotechnology subindustry, Orgenesis's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orgenesis's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orgenesis's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Orgenesis's Pre-Tax Income falls into.



Orgenesis Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Orgenesis's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-50.335+-6.767+-1.987+0+-0.0069999999999908
=-59.10

Orgenesis's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-8.216+-0.236+-0.738+0+0
=-9.19

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-47.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orgenesis  (FRA:45O) Pre-Tax Income Explanation

Orgenesis's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-9.19/0.13
=-7,069.23%

During the past 13 years, Orgenesis's highest Pretax Margin was -33.20%. The lowest was -12159.43%. And the median was -180.26%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orgenesis Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Orgenesis's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Orgenesis (FRA:45O) Business Description

Traded in Other Exchanges
Address
20271 Goldenrod Lane, Germantown, MD, USA, 20876
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.

Orgenesis (FRA:45O) Headlines

No Headlines